Archives

PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

B DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ — PanGIA Biotech, Inc. (“PanGIA”) announced a peer-reviewed clinical study published in Diagnostics, “Urine-Based Machine Learning Assay Detects… Login to continue reading Login…

Read MorePanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis

B WILMINGTON, Del., April 2, 2026 /PRNewswire/ — Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in… Login to continue reading Login…

Read MoreEarendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis